EUVIMEDEUVIMED entdecken
Fallbericht

Medication-Related Osteonecrosis of the Jaw

Yu-Feng Chen iD, Hong-Po Chang

New England Journal of Medicine · 2023

DOI: 10.1056/nejmicm2209172 ↗

Kurz gefasst

Fallbericht in der Zeitschrift New England Journal of Medicine, 2023. Verfasst von Yu-Feng Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Diphosphonates, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 54-year-old woman with metastatic breast cancer who was receiving denosumab therapy presented with right jaw pain. An area of exposed, necrotic bone was visualized in the right mandible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsDiphosphonatesBisphosphonate-Associated Osteonecrosis of the JawHumansJawOsteonecrosis

Substanzen

Bone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Kaohsiung Medical University, Kaohsiung, Taiwan chang610004@gmail.com.

ORCID-Profile: Yu-Feng Chen

Zitieren

APA

Chen, Y. F., & Chang, H. P. (2023). Medication-Related Osteonecrosis of the Jaw. New England Journal of Medicine. https://doi.org/10.1056/nejmicm2209172

Vancouver

Chen YF, Chang HP. Medication-Related Osteonecrosis of the Jaw. New England Journal of Medicine. 2023. doi:10.1056/nejmicm2209172

BibTeX
@article{Chen2023,
  author = {Chen, Yu-Feng and Chang, Hong-Po},
  title = {Medication-Related Osteonecrosis of the Jaw},
  journal = {New England Journal of Medicine},
  year = {2023},
  doi = {10.1056/nejmicm2209172}
}
Kostenlos starten →